PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'AMS Advanced Medical Services GmbH, Munich, Germany.\', \'Novartis Pharma GmbH, Nuernberg, Germany.\', \'Amgen GmbH, Munich, Germany.\', \'Pfizer Deutschland GmbH, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fpubh.2022.804404
?:hasPublicationType
?:journal
  • Frontiers in public health
is ?:pmid of
?:pmid
?:pmid
  • 35252090
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.769
?:rankingScore_hIndex
  • 23
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35252090>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35252090>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all